stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +10.2%
- EPS
- +450.0%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to June 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Total debt
Elanco Animal Health Incorporated's total debt at the end of fiscal 2025 was $4.0B, down 7.04% from $4.3B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $3.9B. Over the past ten years it has ranged from $2.4B (fiscal 2019) to $6.3B (fiscal 2021); the current reading is higher than 38% of that period. Elanco Animal Health Incorporated ranks 5th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $4.0B | (7.04%) |
| FY2024 | $4.3B | (25.16%) |
| FY2023 | $5.8B | (1.06%) |
| FY2022 | $5.8B | (7.64%) |
| FY2021 | $6.3B | 3.13% |
| FY2020 | $6.1B | 160.17% |
| FY2019 | $2.4B | (4.74%) |
| FY2018 | $2.5B | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $3.9B | (1.83%) |
| Mar 2026 | $4.0B | (0.65%) |
| Dec 2025 | $4.0B | (0.17%) |
| Sep 2025 | $4.0B | (4.40%) |
| 28 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ELAN Elanco Animal Health Incorporated | $3.9B |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $3.2B |
| VTRS Viatris Inc. compare | $1.7B |
| ALKS Alkermes plc compare | $1.5B |
| HIMS Hims & Hers Health, Inc. compare | $1.4B |
| RDY Dr. Reddy's Laboratories Ltd compare | $753.0M |
| LNTH Lantheus Holdings, Inc. compare | $571.7M |
| NBIX Neurocrine Biosciences, Inc. compare | $274.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $13.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement